Development and validation of a stability-indicating high performance liquid chromatographic assay for determination of cariprazine in bulk form and in drug product

被引:5
作者
Toujani, E. [1 ,2 ]
Mejri, W. [1 ]
Lassoued, H. E. [2 ]
Toujani, S. [3 ]
Fliss, O. [1 ]
Cheikh, M. H. B. [2 ]
Safta, F. [2 ]
机构
[1] Natl Control Lab Tunisia, Jebel Lakhdar St, Bab Saadoun Tunis 1006, Tunisia
[2] Univ Monastir, Fac Pharm Monastir, Lab Chem Galen & Pharmacol Dev Med LR12ES09, Ibn Sina St, Monastir 5000, Tunisia
[3] Fac Med Tunis, Djebel Lakhdhar St, Bab Saadoun Tunis 1007, Tunisia
来源
ANNALES PHARMACEUTIQUES FRANCAISES | 2023年 / 81卷 / 01期
关键词
Cariprazine; Stability; HPLC; LC-MS; MS; Characterization; RECEPTOR PARTIAL AGONIST; RAPID-DETERMINATION; FORCED DEGRADATION; DOPAMINE D-3; BIPOLAR; RGH-188; SCHIZOPHRENIA; METABOLITES; DISORDER; PLASMA;
D O I
10.1016/j.pharma.2022.08.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study is to develop a stability indicating high performance liquid chromatographic method for the determination of cariprazine in bulk substance and in drug product. The chromatographic separation was carried out using a Phenomenex Kinetex & REG; C18 column (5 & mu;m, 250 x 4.6 mm) and a mobile phase consisting of acetonitrile-potassium dihy-drogen orthophosphate buffer (pH 4; 50 mM) (30:70, v/v), at a flow rate of 1 ml min-1 and UV detection at 248 nm. The column was maintained at 25 degrees C and an injection volume of 20 & mu;L was used. Stress testing of cariprazine bulk substance and drug product was performed according to the International Conference on Harmonization (ICH) Q1A (R2) guideline. Various stress con-ditions were tested including acidic, alkaline and neutral hydrolysis, humidity, oxidation, dry heat and photolysis. A total of three degradation products (DPs) were formed. Among them two DPs were successfully characterized with the liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. & COPY; 2022 Acad & PRIME;emie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:83 / 93
页数:11
相关论文
共 38 条
[1]   Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors [J].
Agai-Csongor, Eva ;
Domany, Gyoergy ;
Nogradi, Katalin ;
Galambos, Janos ;
Vago, Istvan ;
Keseru, Gyoergy Miklos ;
Greiner, Istvan ;
Laszlovszky, Istvan ;
Gere, Aniko ;
Schmidt, Eva ;
Kiss, Bela ;
Vastag, Monika ;
Tihanyi, Karoly ;
Saghy, Katalin ;
Laszy, Judit ;
Gyertyan, Istvan ;
Zajer-Balazs, Maria ;
Gemesi, Larisza ;
Kapas, Margit ;
Szombathelyi, Zsolt .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (10) :3437-3440
[2]   Identification and characterization ofin silico,in vivo,in vitro, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation andin silicotoxicity studies of its metabolites [J].
Al-Shakliah, Nasser S. ;
Attwa, Mohamed W. ;
Kadi, Adnan A. ;
AlRabiah, Haitham .
RSC ADVANCES, 2020, 10 (28) :16231-16244
[3]   The role of degradant profiling in active pharmaceutical ingredients and drug products [J].
Alsante, Karen M. ;
Ando, Akemi ;
Brown, Roland ;
Ensing, Janice ;
Hatajik, Todd D. ;
Kong, Wei ;
Tsuda, Yoshiko .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (01) :29-37
[4]  
[Anonymous], 2003, GUID STAB TEST NEW D
[5]  
[Anonymous], 1996, GUID STAB TEST PHOT
[6]  
[Anonymous], International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use [Internet]. [cited 2016 Jul 1]
[7]   Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies [J].
Attwa, Mohamed W. ;
Kadi, Adnan A. ;
Abdelhameed, Ali S. ;
Alhazmi, Hassan A. .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 :783-793
[8]   Development of validated stability-indicating assay methods - critical review [J].
Bakshi, M ;
Singh, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (06) :1011-1040
[9]  
Blessy M, 2014, J Pharm Anal, V4, P159, DOI 10.1016/j.jpha.2013.09.003
[10]   The role of dopamine D3receptors in the mechanism of action of cariprazine [J].
Calabrese, Francesca ;
Tarazi, Frank, I ;
Racagni, Giorgio ;
Riva, Marco A. .
CNS SPECTRUMS, 2020, 25 (03) :343-351